Search

everythinglearnresearchcommunity

for

Search:↓

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Dermoscopy is useful for identifying and tracking different types of hair loss without scarring.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Hair follicle stem cells are crucial for hair growth and regeneration.

Normal hair thickness varies by scalp area and a mix of hair thicknesses is typical in healthy individuals.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Collagen networks play a key role in hair loss and follicle miniaturization.

Buffy coat PRP is more effective for hair growth in androgenetic alopecia than apheresis PRP.

The buffy coat method slightly outperformed apheresis in patient-reported hair improvement for treating hair loss.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Understanding hair follicle signaling can improve hair disorder treatments.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

Low-level laser therapy is a safe and effective long-term treatment for hair loss, improving hair density and thickness.

PRP shows promise for hair restoration with mild side effects, but more research is needed for clear guidelines.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.